tiprankstipranks
Tenaya Therapeutics initiated with an Outperform at William Blair
PremiumThe FlyTenaya Therapeutics initiated with an Outperform at William Blair
1M ago
Tenaya Therapeutics price target lowered to $16 from $18 at Canaccord
PremiumThe Fly
Tenaya Therapeutics price target lowered to $16 from $18 at Canaccord
2M ago
Tenaya Therapeutics reports Q1 EPS (40c), consensus (42c)
PremiumThe Fly
Tenaya Therapeutics reports Q1 EPS (40c), consensus (42c)
2M ago
Tenaya Therapeutics reports Q4 EPS (40c), consensus (44c)
PremiumThe FlyTenaya Therapeutics reports Q4 EPS (40c), consensus (44c)
4M ago
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4M ago
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
PremiumPress Releases
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
4M ago
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
PremiumPress ReleasesTenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
5M ago
Tenaya Therapeutics Announces Speculative Offering Outlook
PremiumCompany Announcements
Tenaya Therapeutics Announces Speculative Offering Outlook
5M ago
Tenaya Therapeutics Secures $50 Million in Share Sale
PremiumCompany Announcements
Tenaya Therapeutics Secures $50 Million in Share Sale
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100